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Summary
Bee products such as royal jelly, honey and propolis have been reported to possess sev-
eral biological activities. In order to better understand their mechanism of action and, con-
sequently, their efficiency and safety, 'omic' approaches are used. Here cases with proteo-
mic approach are indicated. In addition to studying biological activity at a proteome level,
a proteomic approach for investigation of bee products has also been applied in analyzing
proteins as their (bioactive) components.
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Introduction
Consumers are showing increased interest in bioac-
tive components with health-promoting effects derived
from various sources. Among them, bee products such
as propolis, honey and royal jelly have generated con-
siderable interest. They contain many bioactive compo-
nents that have been shown to possess several biological
properties. Honey has been used since ancient times as
part of traditional medicine. Several functions such as
antibacterial, antioxidant, antitumour, anti-inflamatory,
antibrowning, and antiviral have been reported. Propolis
is a resinous substance that bees collect from the exu-
dates of plants and use to seal holes in the beehive. This
substance has been used in folk medicine since ancient
times, due to its many biological properties such as anti-
tumour, antioxidant, antimicrobial, anti-inflammatory, and
immunomodulatory effects, among others. Royal jelly as
exclusive food of the queen honeybee has been demon-
strated to possess numerous functional properties such
as antibacterial, anti-inflammatory, vasodilative and hy-
potensive, disinfectant, antioxidant, antihypercholestero-
lemic, and antitumour activities (1–3). Biological activities
of propolis are mainly attributed to the phenolic com-
pounds, while in honey in addition to phenolic com-
pounds, proteins (peptides) have also been reported to
show similar properties (3–5). Biological activities of royal
jelly are mainly attributed to bioactive fatty acids, pro-
teins and phenolic compounds (1).
A proteomic approach in investigating bee products
is focused either on analyzing proteins as (bioactive) com-
ponents of bee products or studying their biological
activity at proteome level.
Proteins as (Bioactive) Components of Bee
Products
A proteomic approach in analyzing proteins as (bio-
active) components of royal jelly has been widely report-
ed. Since up to 50 % (dry mass) of royal jelly is protein,
proteome analysis is a promising starting point for at-
tempts to identify the proteins that provide health-pro-
moting effects (6). Many studies have used either a gel-
-based proteomic approach, including sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
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and two-dimensional polyacrylamide gel electrophoresis
(2-D PAGE), mostly in combination with mass spectro-
metry (MS) (7–16), or gel-free proteomics (13) merely to
analyze and/or to identify royal jelly proteins. Further-
more, Schönleben et al. (6) applied various methods for
the pre-fractionation and separation of royal jelly pro-
teins in order to circumvent the shortcomings of indivi-
dual techniques such as 2-D PAGE or multidimensional
chromatography, which can only yield certain subpopu-
lations of a proteome due to the specific bias of each
method. In this way they achieved a high coverage of
the royal jelly proteome and were able to identify a total
of 20 different proteins, as well as to demonstrate a very
high degree of cleavage of different proteins of the ma-
jor royal jelly protein (MRJP) family. Furthermore, they
investigated the protein phosphorylation of royal jelly pro-
teins, and identified and located two phosphorylation sites
within venom protein 2. Similarly, Furusawa et al. (11)
reported potentially post-translationally modified (phos-
phorylated and glycosylated) royal jelly proteins based
on Pro-Q diamond phosphoprotein and emerald glyco-
protein gel stains using 2-D PAGE. Zhang et al. (17) ana-
lyzed post-translational modifications (PTM) of royal jelly
proteins by using complementary proteome strategies of
two-dimensional gel electrophoresis (2-DE), shotgun anal-
ysis in combination with high performance liquid chro-
matography-chip/electrospray ionization quadrupole time-
-of-flight/tandem mass spectrometry and bioinformatics.
Phosphorylation was characterized in MRJP 1, MRJP 2
and apolipophorin-III-like protein, and a new site was
localized in venom protein 2 precursor. Methylation and
deamidation were also identified in most of the MRJPs.
The results indicate that methylation is the most import-
ant PTM of MRJPs that triggers the polymorphism of
MRJP 1–5 in the royal jelly proteome. The study by Bí-
liková et al. (18) illustrated multifunctionality of proteins
of honeybee royal jelly and how their neofunctionaliza-
tion results from various PTMs of maternal proteins.
Honey is another bee product containing proteins,
so SDS-PAGE, 2-D PAGE and MS have been used to ana-
lyze and identify major honey proteins (19,20). Di Giro-
lamo et al. (5) analyzed honey from chestnut, acacia, sun-
flower, eucalyptus and orange for its proteome, using SDS
PAGE and 2-D PAGE in order to investigate the origin
of its proteins. It was shown that all the proteins iden-
tified (except one, the enzyme glyceraldehyde-3-phos-
phate dehydrogenase from Mesembryanthemum crystalli-
num) were not of plant origin but belonged to the Apis
mellifera proteome. Among the total proteins identified
five belonged to the family of major royal jelly proteins
1–5 and were also the most abundant ones in any type
of honey, together with a-glucosidase and defensin-1. It
thus appears that honey has a proteome resembling the
royal jelly proteome (but with considerably fewer spe-
cies), except that its protein concentration is lower by
three to four orders of magnitude as compared to royal
jelly. Similarly, Kwakman et al. (4) demonstrated by using
SDS-PAGE and Western blotting that honey contains an
antimicrobial peptide, bee defensin-1, and that this pep-
tide substantially contributes to the bacterial activity. Ba-
roni et al. (21) reported on the development of a novel
alternative method for assessing the floral origin of honey
samples based on the study of honey proteins, using SDS-
-PAGE immunoblot techniques.
In the case of propolis, protein profiling using a pro-
teomic approach has not been reported.
Investigating the Biological Activity of Bee
Products in the Cell at Proteome Level
To investigate the biological activity of bee products,
studies have mainly been conducted at the level of whole
experimental animals and cells, while biological activity
at a molecular level is less known (1–3). Both food as a
whole and individual bioactive compounds interact with
our body at system, organ, cellular and molecular levels
(22). At a molecular level, they can essentially affect every
step in the flow of genetic information, from gene ex-
pression to protein synthesis and protein degradation, and
thereby alter metabolic functions in the most complex
way (23,24).
Omic technologies enable elucidation of the molecu-
lar basis for the activity of bioactive components of func-
tional foods or other sources, leading to a better under-
standing of their mechanism of action. Among them,
proteomics has an important advantage; it investigates
the proteins that carry out functions. Proteins are the real
players of life; they build our cellular and extracellular
structures, provide and respond to messages (growth fac-
tors, hormones, receptors, cytosol and nuclear proteins),
enable the transport of nutrients and metabolites in blood,
to and in the cells, enable metabolism (enzymatic reac-
tions), protect the organism (antibodies, blood coagula-
tion factors) and regulate gene expression. Signalling path-
ways are concerned with changes in protein expression,
and with most pathophysiological conditions. Using pro-
teomic technology, it is possible to determine changes in
protein expression and to identify the proteins themselves.
Moreover, information about the presence of isoforms,
post-translational modifications and protein interactions
can also be obtained (23,25).
The effect of bioactive components on proteins gener-
ally occurs as an effect on protein abundance, an effect
on post-translational modification or as an interaction (bio-
active component-protein). Post-translational modifications
of proteins, as well as their direct interaction with bio-
active components, can result in changes of the three-
-dimensional structure of such affected proteins. Their
original functions are thus modulated, resulting, for ex-
ample, in reduced activity in the case of enzymes or
changes in recognition ability between molecules, such
as in protein-protein interactions or ligand-receptor in-
teractions (26,27).
As already mentioned, proteomic tools enable the de-
tection of changes that have occurred in proteins target-
ed by bioactive compounds. In order to gain a full pic-
ture of the proteome of any cell, and consequently possible
targets, it is essential to use a subcellular proteomic ap-
proach (28,29). Subcellular proteomics has the advantage
not only of relating proteins to functional compartments
within eukaryotic cells, but also of reducing the com-
plexity of a whole cell or a tissue protein extract, which
can often prevent satisfactory proteomic analysis. Speci-
fically, it allows the identification of novel and low-ab-
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undance proteins that can otherwise remain masked by
those expressed at higher levels when the total prote-
ome of a cell or tissue is investigated (30). Particularly in
the case of certain regulatory proteins, such as kinases,
transcription factors and some membrane receptors, ana-
lysis of subcellular compartments is the strategy of choice
(31). This approach is powerful enough to select with
high confidence the proteins truly involved in a given
biological process (30).
In the case of bee products, such as royal jelly, prop-
olis and honey, some studies have been carried out at a
molecular level, but mostly by analyzing gene expres-
sion for a limited number of candidate genes (1–3). This
is a limitation, since a reduced number of genes may not
provide insight into the causative relationship between a
bioactive food component and its biological effect (24,
32). Analysis of global gene expression at a proteome level
offers better possibilities. However, the application of pro-
teomics in studying the mechanism of activity of bio-
active components of bee products is still fairly limited.
Barlak et al. (33) investigated the effect of dimethyl
sulphoxide and water extracts of Turkish propolis on the
proteome of a prostate cancer cell line using surface-en-
hanced laser desorption ionization/time-of-flight mass
spectrometry (SELDI-TOF MS). It was concluded that
dimethyl sulphoxide and water extracts of Turkish prop-
olis may have an antiproliferative effect through differ-
entiating the protein expression profile in PC-3 prostate
cancer cell lines, together with their antioxidant capacity.
Two studies (34,35) are summarized below that illustrate
the effect of propolis and royal jelly on a proteome, using
yeast Saccharomyces cerevisiae as a model organism. This
lower eukaryote is an appropriate model organism for
the study of fundamental eukaryotic cellular processes,
such as their stress responses and metabolic pathway
(36–39). Since many genes from the yeast Saccharomyces
cerevisiae are conserved in humans and a number of
powerful genomic tools and methodologies have been
developed for this model system, yeast is making a major
contribution to the field of chemical genetics (40). In
drug research, where one of the major challenges is to
identify the proteins and cellular pathways affected by a
drug, several different approaches are being developed
using Saccharomyces cerevisiae as a model organism (41).
Comparative genomic studies have shown that 40 % of
yeast proteins share amino acid sequence similarity with
at least one human protein (42), and 30 % of genes with
a recognized involvement in human disease have a yeast
orthologue (43). Furthermore, yeast has many technical
advantages over human cells. It is well suited to high-
-throughput methods because of its rapid life cycle, it
can grow as dispersed cells in liquid or as colonies on
solid media, and its culture requires neither an elaborate
sterile technique nor expensive media. It is highly ame-
nable to genetic modifications such as gene disruption,
deletion and replacement (44). Experiments with yeast
will always be technically easier, more rapid and much
less costly than experiments with human cells, and it is
anticipated that yeast will remain a good first line of
attack in the hunt for drugs (41), as well as bioactive
compounds from different sources.
In the study of Cigut et al. (34), the effect of etha-
nolic extract of propolis (EEP), as well as its particular
fraction, was investigated at cellular and proteome levels.
While the effects of both of these treatments on the total
proteome were not significant, intensive changes were
found in the mitochondrial proteome. Thus, using a sub-
cellular proteomic approach, the a subunit of mitochon-
drial F0F1-ATP synthase (Atp1), Mn superoxide dismu-
tase (Mn SOD) and peroxiredoxin (Prx1) were found to
be targets; decreased levels of all proteins were observed.
F0F1-ATP synthase has been suggested as a good mole-
cular target for drugs in the treatment of various dis-
eases and in the regulation of the energy metabolism (45).
In the case of phenolic compounds, it has been shown
that these compounds often target F0F1-ATP synthase
(45–47). Mn SOD and Prx both belong to endogenous anti-
oxidant defence systems and their decreased levels might
be due to reduced intracellular oxidation after exposure
to exogenous antioxidants, which was also measured in
the study. Similarly, Jamnik et al. (35) showed a reduced
level of Cu/Zn SOD in the yeast S. cerevisiae when ex-
posed to royal jelly, which decreased intracellular oxida-
tion. The reduced levels of endogenous antioxidant pro-
teins and reduced intracellular oxidation measured in
both studies indicate that both propolis and royal jelly
are likely to be acting directly as radical scavengers, and
not indirectly as pro-antioxidants. The latter would lead
to decreased intracellular oxidation due to increased levels
of endogenous antioxidant proteins (48). In yeast cells
treated with royal jelly, a total of 22 spots were found to
be differentially expressed compared to untreated cells.
The densities of six spots were decreased and five spots
were found up-regulated, while eleven protein spots were
detected only in cells treated with royal jelly. Among the
identified spots, in addition to Cu/Zn SOD, there were
a regulating protein (transcription modulator WTM1) and
proteins that play an important role in proteolysis and
several metabolic pathways (vacuolar protease B, glycine
cleavage T protein GCV1, vacuolar H+-ATPase) (35). Both
these studies (34,35) offered insight into the mechanism
of action of propolis and royal jelly also at a proteome
level, specifically in terms of antioxidant activity.
Besides the antioxidant and antiproliferative activity
of bee products, antimicrobial effect studied by using pro-
teomic approach has been reported. The effect of manu-
ka honey on protein expression was investigated in meti-
cillin-resistant S. aureus (MRSA). Namely, honey has been
used to eradicate MRSA strains from wounds, but its
mode of action is not yet understood. Using 2-D PAGE
combined with matrix-assisted laser desorption/ionisa-
tion time-of-flight mass spectrometry (MALDI-TOF MS),
a downregulation of universal stress protein in honey-
-treated cells compared to untreated samples was iden-
tified. This protein is involved in the stress stamina re-
sponse and its downregulation could help to explain the
inhibition of MRSA by manuka honey (49). Similarly,
Packer et al. (50) studied the non-peroxide antibacterial
effects of this honey on the proteome of the common
wound pathogen Staphylococcus aureus. Treatment with
manuka honey resulted in a significant decrease in the
bacterial cell growth rate as well as downregulation of
ten and upregulation of two proteins. The differentially
expressed proteins have roles in ribosomal function,
protein synthesis, metabolic processes and transcription.
Manuka honey uniquely caused downregulation of two
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proteins (dihydrolipoamide dehydrogenase (DLD) and
elongation factor Tu (EF-Tu)) associated with two of these
pathways as well as upregulation of one stress-related
protein (cold shock protein C (CspC)). The proteomic
profile following a treatment with manuka honey dif-
fered from the profiles of other antibacterial agents, in-
dicating a unique mode of action and its potential value
as a novel antimicrobial agent.
Conclusions
Knowledge of the profiles and characteristics of pro-
teins of bee products gives valuable information con-
cerning their quality. Changes related to proteins, such
as contamination, adulteration, degradation, oxidation or
polymorphism can be readily identified from proteomic
analysis. Analysis of major proteins in honey and royal
jelly is thus a useful method for discriminating honey
and royal jelly produced by different honeybee species
(20,51). On the other hand, proteomic approach in the
field of bee products is oriented towards studying their
biological activity at a proteome level, especially in ex-
plaining antioxidant, antiproliferative and antimicrobial
activity. The characterization of changes at a proteome
level with functional data from the established biochem-
ical and physiological methods can result in a better under-
standing of the mode of action of bioactive compounds.
Changes in protein profile may alter fundamental cellu-
lar processes and metabolic pathways, leading to changed
cell functions. Therefore, knowledge of proteins targeted
by bee products could be the basis for the development
of biomarkers for validation of their efficacy and/or
safety (26).
Proteomics integrated with other advanced techno-
logies (genomics, transcriptomics, metabolomics and bio-
informatics) will greatly facilitate elucidation of the effects
of bioactive components on the global expression of
genetic information and cell function, without making
assumptions about what to look for in terms of risk (52).
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